{"nct_id":"NCT04150497","title":"Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)","status":"RECRUITING","status_verified_date":"2025-09","start_date":"2019-10-14","start_date_type":"ACTUAL","primary_completion_date":"2026-06-30","primary_completion_date_type":"ESTIMATED","completion_date":"2026-06-30","completion_date_type":"ESTIMATED","phases":["PHASE1","PHASE2"],"tickers":["CLLS"]}